8-K
filed May 15, 2026, 5:15 PM ET
ticker VTR
CIK 0000740260
other material
confidence high
sentiment neutral
materiality 0.60
Ventas ups ATM equity capacity to $3.0B; all 12 directors elected at annual meeting
Ventas, Inc.
- Amendment No. 3 to ATM Sales Agreement raises aggregate gross sales price to $3.0B, excluding prior sales.
- Annual meeting had 93.5% voter turnout; all 12 director nominees elected with majority votes.
- Say-on-pay proposal approved with 91.6% of votes cast in favor; KPMG ratification passed.
- EVP Peter J. Bulgarelli retired May 1, 2026; separation agreement provides prorated 2026 bonus subject to release and restrictive covenants.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Peter J. Bulgarelli retired as Executive Vice President, Outpatient Medical & Research at Ventas, Inc..
- Action
- retired
- Role
- Executive Vice President, Outpatient Medical & Research
Exact text from the filing
On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Ventas, Inc. shareholders approved To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year at the 2026-05-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
Proposal 3: To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Ventas, Inc. shareholders approved To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers at the 2026-05-13 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
Proposal 2: To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Ventas, Inc. shareholders approved To elect the 12 director nominees named in the Proxy Statement to serve until the 2027 Annual Meeting of Stockholders at the 2026-05-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
Proposal 1: To elect the 12 director nominees named in the Proxy Statement to serve until the 2027 Annual Meeting of Stockholders
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.